Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03899311 · ClinicalTrials.gov registry record
A Protein-sparing Modified Fast for Children and Adolescents With Severe Obesity (PSMF)
A clinical trial of Obesity, Childhood, sponsored by Ihuoma Eneli.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT03899311: Completed study of Obesity, Childhood, sponsored by Ihuoma Eneli.
NCT03899311 is a study of Obesity, Childhood that has completed, run by Ihuoma Eneli. The registered enrollment target is 30 participants, below the 343-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03899311, a study of Obesity, Childhood, has completed, sponsored by Ihuoma Eneli.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 12 month prospective observational cohort study of the outpatient protein-sparing modified fast diet for children with severe obesity and serious comorbid condition(s). The study will enroll 30 Center for Healthy Weight and Nutrition patients aged 11-19 years who have been placed on a protein sparing modified fast as part of their treatment plan. The study-specific procedures consist of questionnaires/interviews on diet and PA behaviors, adherence and self-efficacy measures, data abstraction from the chart and tracking of activity using a Fitbit.
Primary Outcome
The percentage of patients and families recruited over all approached eligible patients, during the recruitment period
Conditions Studied
Interventions
- OTHER protein-sparing modified fast diet
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2019-02-28 |
What the finished NCT03899311 record still lists
NCT03899311 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 343-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Obesity, Childhood appearing as the primary indexed condition, and to 1 intervention - of which protein-sparing modified fast diet is the first listed.
NCT03899311 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03899311 about?
NCT03899311 is a clinical study titled "A Protein-sparing Modified Fast for Children and Adolescents With Severe Obesity (PSMF)". This is a 12 month prospective observational cohort study of the outpatient protein-sparing modified fast diet for children with severe obesity and serious comorbid condition(s). The study will enroll 30 Center for Healthy Weight and Nutrition patients aged 11-19 years who have been placed on a prot...
What is the current status of trial NCT03899311?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-01-01. Estimated completion is 2019-02-28.
What conditions does trial NCT03899311 study?
This clinical trial studies the following conditions: Obesity, Childhood.
What interventions are being tested in trial NCT03899311?
The interventions under investigation include: protein-sparing modified fast diet (OTHER).
Who is sponsoring clinical trial NCT03899311?
This trial is sponsored by Ihuoma Eneli, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03899311 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity, Childhood
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03899311's enrollment target sits among peer trials
30 50th of 53 higher than 4 of 53 other Obesity, Childhood trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity, Childhood trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Breastmilk in Response to a Bout of Exercise
RECRUITING
-
Food-Body-Mind Intervention (16 Weeks)
RECRUITING · Phase 2
-
Interoception and Eating Behaviors in Children
RECRUITING
-
Bringing Weight Management Into the Primary Care Pediatric Practice
RECRUITING
-
Increasing Food Literacy in Preschoolers to Reduce Obesity Risk
RECRUITING · NA
-
A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI